Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?

D Vigil, J Cherfils, KL Rossman, CJ Der - Nature Reviews Cancer, 2010 - nature.com
There is now considerable and increasing evidence for a causal role for aberrant activity of
the Ras superfamily of small GTPases in human cancers. These GTPases function as GDP …

Autistic spectrum disorders: A review of clinical features, theories and diagnosis

M Fakhoury - International journal of developmental neuroscience, 2015 - Elsevier
Autism spectrum disorder (ASD) is a set of neurodevelopmental disorders that is among the
most severe in terms of prevalence, morbidity and impact to the society. It is characterized by …

Autism genetics

AM Persico, V Napolioni - Behavioural brain research, 2013 - Elsevier
Autism spectrum disorder (ASD) is a severe neuropsychiatric disease with strong genetic
underpinnings. However, genetic contributions to autism are extremely heterogeneous, with …

Neuropsychopathology of autism spectrum disorder: complex interplay of genetic, epigenetic, and environmental factors

R Bhandari, JK Paliwal, A Kuhad - … food intervention and therapy for autism …, 2020 - Springer
Autism spectrum disorder (ASD) is a complex heterogeneous consortium of pervasive
development disorders (PDD) which ranges from atypical autism, autism, and Asperger …

Genetics of tuberous sclerosis complex: implications for clinical practice

C Caban, N Khan, DM Hasbani… - The application of clinical …, 2016 - Taylor & Francis
Tuberous sclerosis complex (TSC) is a multisystem disorder that results from heterozygous
mutations in either TSC1 or TSC2. The primary organ systems that are affected include the …

Review of the treatment options for epilepsy in tuberous sclerosis complex: towards precision medicine

S Schubert-Bast, A Strzelczyk - Therapeutic advances in …, 2021 - journals.sagepub.com
Tuberous sclerosis complex (TSC) is a rare genetic disorder caused by mutations in the
TSC1 or TSC2 genes, which encode proteins that antagonise the mammalian isoform of the …

Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy

P Curatolo - Pediatric neurology, 2015 - Elsevier
Background Tuberous sclerosis complex is a multiorgan disease resulting from a mutation of
one of two TSC genes. The two gene products form a functional complex that regulates the …

Mosaic disorders of the PI3K/PTEN/AKT/TSC/mTORC1 signaling pathway

N Nathan, KM Keppler-Noreuil… - Dermatologic …, 2017 - derm.theclinics.com
Mosaicism may occur as a somatic mutation occurring during embryogenesis, resulting in an
organism composed of 2 (or more) genetically distinct cell lineages. 1 The resulting …

Biomarkers for pancreatic neuroendocrine neoplasms (PanNENs) management—an updated review

M Bocchini, F Nicolini, S Severi, A Bongiovanni… - Frontiers in …, 2020 - frontiersin.org
Pancreatic neuroendocrine tumors (PanNENs) are rare sporadic cancers or develop as part
of hereditary syndromes. PanNENs can be both functioning and non-functioning based on …

Rapamycin and rapalogs for tuberous sclerosis complex

TH Sasongko, K Kademane, SCS Hou… - Cochrane Database …, 2023 - cochranelibrary.com
Background Potential benefits of rapamycin or rapalogs for treating people with tuberous
sclerosis complex (TSC) have been shown. Currently everolimus (a rapalog) is only …